Bruker Corporation

NasdaqGS:BRKR Stock Report

Market Cap: US$5.9b

Bruker Future Growth

Future criteria checks 4/6

Bruker is forecast to grow earnings and revenue by 38.6% and 5.1% per annum respectively. EPS is expected to grow by 41% per annum. Return on equity is forecast to be 22.2% in 3 years.

Key information

38.6%

Earnings growth rate

41.0%

EPS growth rate

Life Sciences earnings growth16.0%
Revenue growth rate5.1%
Future return on equity22.2%
Analyst coverage

Good

Last updated17 Apr 2025

Recent future growth updates

Recent updates

Does Bruker (NASDAQ:BRKR) Have A Healthy Balance Sheet?

Apr 26
Does Bruker (NASDAQ:BRKR) Have A Healthy Balance Sheet?

Bruker Corporation: An Investor Could Do Worse

Apr 07

Should You Think About Buying Bruker Corporation (NASDAQ:BRKR) Now?

Apr 04
Should You Think About Buying Bruker Corporation (NASDAQ:BRKR) Now?

Investors Interested In Bruker Corporation's (NASDAQ:BRKR) Earnings

Mar 20
Investors Interested In Bruker Corporation's (NASDAQ:BRKR) Earnings

Bruker Corporation Pivots To Capitalize Its Growing TAM

Jan 19

Does Bruker (NASDAQ:BRKR) Have A Healthy Balance Sheet?

Jan 14
Does Bruker (NASDAQ:BRKR) Have A Healthy Balance Sheet?

Is Bruker Corporation (NASDAQ:BRKR) Potentially Undervalued?

Dec 27
Is Bruker Corporation (NASDAQ:BRKR) Potentially Undervalued?

Bruker's (NASDAQ:BRKR) Anemic Earnings Might Be Worse Than You Think

Nov 14
Bruker's (NASDAQ:BRKR) Anemic Earnings Might Be Worse Than You Think

Bruker: Still Challenged, Certainly Margins

Nov 02

Earnings Tell The Story For Bruker Corporation (NASDAQ:BRKR)

Oct 25
Earnings Tell The Story For Bruker Corporation (NASDAQ:BRKR)

We Think Bruker (NASDAQ:BRKR) Is Taking Some Risk With Its Debt

Sep 10
We Think Bruker (NASDAQ:BRKR) Is Taking Some Risk With Its Debt
author-image

Tactical Acquisitions And Innovation Drive Market Expansion And Revenue Growth

Aug 25 Strategic acquisitions and Project Accelerate 2.0 aim to significantly expand Bruker's market and improve operational efficiencies, boosting revenue growth and net margins.

Bruker: Multiple Risks And Declining Returns On Capital Aren't Priced In

Aug 22

Is It Too Late To Consider Buying Bruker Corporation (NASDAQ:BRKR)?

Jul 22
Is It Too Late To Consider Buying Bruker Corporation (NASDAQ:BRKR)?

Bruker Corporation's (NASDAQ:BRKR) Business Is Yet to Catch Up With Its Share Price

Jun 09
Bruker Corporation's (NASDAQ:BRKR) Business Is Yet to Catch Up With Its Share Price

Bruker: A Confusing Acquisition Spree

May 31

Bruker's (NASDAQ:BRKR) Promising Earnings May Rest On Soft Foundations

May 09
Bruker's (NASDAQ:BRKR) Promising Earnings May Rest On Soft Foundations

Bruker Corporation: An Aggressive Acquisition Strategy

Apr 24

Bruker Offers Upside With Key Enabling Technologies For Future Bio-Pharma Research

Apr 11

Earnings and Revenue Growth Forecasts

NasdaqGS:BRKR - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20273,9204233965268
12/31/20263,68337032346013
12/31/20253,4822443844529
12/31/20243,366113136251N/A
9/30/20243,241305157267N/A
6/30/20243,120352168273N/A
3/31/20243,001402181284N/A
12/31/20232,965427243350N/A
9/30/20232,818319206316N/A
6/30/20232,715319201342N/A
3/31/20232,621312149284N/A
12/31/20222,531297145274N/A
9/30/20222,506275119242N/A
6/30/20222,476274114196N/A
3/31/20222,458282176262N/A
12/31/20212,418277190282N/A
9/30/20212,362270254347N/A
6/30/20212,264238312405N/A
3/31/20212,118204304395N/A
12/31/20201,988158235332N/A
9/30/20201,960158169265N/A
6/30/20201,970165140235N/A
3/31/20202,035177141234N/A
12/31/20192,073197140213N/A
9/30/20192,026207144210N/A
6/30/20191,972189124185N/A
3/31/20191,925184159210N/A
12/31/20181,896180191240N/A
9/30/20181,87398N/A211N/A
6/30/20181,84292N/A219N/A
3/31/20181,81384N/A166N/A
12/31/20171,76679N/A154N/A
9/30/20171,706151N/A142N/A
6/30/20171,664161N/A142N/A
3/31/20171,621152N/A177N/A
12/31/20161,611154N/A131N/A
9/30/20161,619146N/A190N/A
6/30/20161,621111N/A208N/A
3/31/20161,646119N/A188N/A
12/31/20151,624102N/A229N/A
9/30/20151,65466N/A149N/A
6/30/20151,67760N/A108N/A
3/31/20151,73955N/A123N/A
12/31/20141,80957N/A114N/A
9/30/20141,85366N/A176N/A
6/30/20141,87277N/A201N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: BRKR's forecast earnings growth (38.6% per year) is above the savings rate (2.8%).

Earnings vs Market: BRKR's earnings (38.6% per year) are forecast to grow faster than the US market (14.1% per year).

High Growth Earnings: BRKR's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: BRKR's revenue (5.1% per year) is forecast to grow slower than the US market (8.2% per year).

High Growth Revenue: BRKR's revenue (5.1% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: BRKR's Return on Equity is forecast to be high in 3 years time (22.2%)

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/04/27 16:34
End of Day Share Price 2025/04/25 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Bruker Corporation is covered by 30 analysts. 13 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Luke SergottBarclays
Michael RyskinBofA Global Research
Jose De Jesus HarescoBrean Capital